HBV
Os inibidores do HBV são compostos projetados para atingir e inibir várias etapas do ciclo de vida do vírus da hepatite B (HBV). Esses inibidores podem interferir na replicação, montagem ou liberação viral, reduzindo assim a carga viral e ajudando a gerenciar infecções crônicas por HBV. A pesquisa sobre inibidores do HBV é crucial para o desenvolvimento de terapias antivirais eficazes para prevenir doenças hepáticas e câncer associados ao HBV. Na CymitQuimica, oferecemos uma variedade de inibidores do HBV para apoiar sua pesquisa em virologia, desenvolvimento de medicamentos antivirais e controle de doenças infecciosas.
Foram encontrados 171 produtos para "HBV".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
AB-836
CAS:AB-836, an orally active hepatitis B virus (HBV) capsid inhibitor, hampers viral replication by engaging with the HBV core protein.Fórmula:C20H15F3N4O2Cor e Forma:SolidPeso molecular:400.35SHR5133
CAS:SHR5133 is a potent, orally active regulator of HBV capsid assembly that reduces HBV DNA (EC50: 26.6 nM).Fórmula:C19H18F4N6O2Cor e Forma:SolidPeso molecular:438.38HBV-IN-30
CAS:HBV-IN-30, a flavone derivative, inhibits cccDNA in HBV research.Fórmula:C22H18BrClO6Cor e Forma:SolidPeso molecular:493.73Besifovir Dipivoxil maleate
CAS:Besifovir Dipivoxil maleate, an oral HBV prodrug (LB80380), suppresses HBV DNA in naive and lamivudine-resistant CHB cases.Fórmula:C22H34N5O8PPureza:98%Cor e Forma:SolidPeso molecular:527.51Helioxanthin 8-1
CAS:Helioxanthin 8-1, an analogue of helioxanthin, exhibits significant in vitro anti-HBV/HCV/HSV-1/HIV activity with EC50 of >5/10/1.4/15 μM.Fórmula:C20H12N2O6Pureza:98%Cor e Forma:SolidPeso molecular:376.32HBV-IN-13
CAS:HBV-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg).Fórmula:C22H25NO7Cor e Forma:SolidPeso molecular:415.44IR415
CAS:IR415 selectively interacts with Hepatitis B virus X protein (HBx, Kd = 2 nM) and blocks HBV-mediated RNAi suppression, reverses the inhibitory effect of HBxFórmula:C13H14F2N4SPureza:99.85%Cor e Forma:White SolidPeso molecular:296.34Ref: TM-T11669
5mg43,00€1mL*10mM (DMSO)47,00€10mg71,00€25mg128,00€50mg215,00€100mg318,00€200mg444,00€ZINC20451377
CAS:ZINC20451377 is a small molecule compound that binds with high affinity to the hepatitis B surface antigen (HBsAg), with a dissociation constant (Kd) of 65.3 nM. It reduces HBsAg levels and HBV particle secretion in HBV cell culture models.Fórmula:C32H38N4O3Cor e Forma:SolidPeso molecular:526.67HEC72702
CAS:HEC72702: New HBV capsid inhibitor, from GLS4. No CYP1A2, CYP3A4, CYP2B6 induction at 10μM.Fórmula:C24H26BrFN4O5SCor e Forma:SolidPeso molecular:581.45HBV-IN-17
CAS:HBV-IN-17 (compound 8) is a potent regulator of HBV capsid assembly (EC50: 511 nM).Fórmula:C17H15F6N5O2Cor e Forma:SolidPeso molecular:435.32HBV-IN-41
CAS:HBV-IN-41 (compound 45) is a potent, orally active inhibitor of Hepatitis B Virus (HBV), exhibiting an EC50 value of 0.027μM [1].Fórmula:C18H19ClFN5O3Pureza:98%Cor e Forma:SolidPeso molecular:407.83Emtricitabine triphosphate tetrasodium salt
CAS:Emtricitabine triphosphate tetrasodium salt is the tetrasodium salt form of the phosphorylated anabolite (-)-Emtricitabine triphosphate, an active nucleosideFórmula:C8H9FN3Na4O12P3SPureza:98%Cor e Forma:SolidPeso molecular:575.11Tobevibart
CAS:Tobevibart, an IgG1-lambda humanized monoclonal antibody targeting the hepatitis B virus (HBV) surface envelope protein, exhibits antiviral activity [1].Pureza:98%Cor e Forma:LiquidCarbovir
CAS:Carbovir, an NRTI, induces mitochondrial toxicity in human liver cancer cells.Fórmula:C11H13N5O2Cor e Forma:SolidPeso molecular:247.25ent-Entecavir
CAS:Ent-Entecavir, an enantiomeric impurity of Entecavir (an oral HBV drug), inhibits HBV replication as a reverse transcriptase inhibitor.Fórmula:C12H15N5O3Cor e Forma:SolidPeso molecular:277.28Tenofovir amibufenamide
CAS:Tenofovir amibufenamide (HS-10234) 是一种 Tenofovir 前药，是一种具有口服活性的抗病毒化合物。Tenofovir amibufenamide 对乙型肝炎病毒 (HBV)具有抑制作用，可用于慢性乙型肝炎 (CHB) 研究。Fórmula:C22H31N6O5PPureza:99.19% - 99.87%Cor e Forma:SolidPeso molecular:490.49HBV-IN-31
CAS:HBV-IN-31: strong cccDNA inhibitor, anti-HBV, IC50=0.13 µM HBsAg, hampers cell growth.Fórmula:C23H18ClNO6Cor e Forma:SolidPeso molecular:439.85HBV-IN-11
CAS:HBV-IN-11 is a potent inhibitor of HBsAg secretion (EC50: 0.46 μM).Fórmula:C21H24ClNO6Cor e Forma:SolidPeso molecular:421.87HBV-IN-20
HBV-IN-20 is a potent, orally active HBV inhibitor (EC50: 0.46 μM). HBV-IN-20 is a classical type II CpAM (core protein assembly regulator).Cor e Forma:SolidHBV-IN-19 TFA
CAS:HBV-IN19 TFA suppresses HBsAg, hampers HBV infection, and aids in HBV research.Fórmula:C26H31F3N2O8Cor e Forma:SolidPeso molecular:556.53
